Skip to main content
. Author manuscript; available in PMC: 2022 Dec 13.
Published in final edited form as: J Clin Exp Neuropsychol. 2020 Aug 11;42(7):647–659. doi: 10.1080/13803395.2020.1798879

Table 3.

Cognitive performance in African American women with parental history of AD.

Total Normal
IL-10 (Raw)
Elevated IL-10 (Raw) Mean Difference Raw p Effect Sizes (95% Cl) (Raw) Multivariate M difference (Adj) p

Serial 3s % Correct (%) 90.41 ± 16.3 92.52 ± 11.4 87.85 ± 21.0 4.67 (−17.75,8.41) 0.464 0.28 (−0.5, 1) −4.33 (−16.5,7.8) 0.461
Montreal Cognitive Assessment (/30) 25.74 ± 2.71 25.88 ± 3.0 25.57 ± 2.3 0.31 (−2.34,1.72) 0.756 0.11 (−0.6, 0.9) 0.54 (−2.4, 3.4) 0.701
Delayed Recall (MOCA) 3.61 ± 1.1 3.53 ± 1.3 3.71 ± 0.8 −0.18 (−0.65,1.02) 0.654 −0.16 (−0.9, 0.6) −0.12 (−1.4, 1.1) 0.847
Brooks Spatial Memory (% Correct) 68.84 ± 18.0 68.59 ± 15.1 69.14 ± 21.5 −0.55 (−12.92,14.03) 0.933 −0.03 (−0.8, 0.7) −2.16 (−23.4, 19.1) 0.832
BPST Span 3.74 ± 1.0 3.59 ± 1.1 3.93 ± 0.9 −0.34 (−0.4,1.08) 0.354 −0.34 (−1.1, 0.4) −0.7 (−1.8, 0.4) 0.195
BPST Total Correct Trials 4.29 ± 1.4 4.00 ± 1.3 4.64 ± 1.6 −0.64 (−0.41,1.7) 0.223 −0.45 (−1.2, 0.3) −0.98 (−2.3, 0.4) 0.140
Corsi Span 4.23 ± 1.0 4.18 ± 0.6 4.29 ± 1.3 −0.11 (−0.67,0.89) 0.772 −0.11 (−0.9, 0.6) −0.18 (−1.3, 0.9) 0.738
Corsi Total Correct Trials 5.42 ± 1.5 5.47 ± 1.1 5.36 ± 1.9 0.11 (−1.32,1.09) 0.846 0.07 (−0.7, 0.8) 0.06 (−1.6, 1.7) 0.939
TMT Difference (B-A) (s) 43.59 ± 24.6 37.26 ± 22.7 51.27 ± 25.3 −14.01 (−3.64,31.67) 0.115 −0.59 (−1.3, 0.2) −17.92 (−42.4, 6.6) 0.140
TMT Proportion (B-A)/A 1.84 ± 0.9 1.51 ± 0.7 2.24 ± 1.0 −0.73 (0.11,1.34) 0.022 −0.87 (−1.6, −0.1) −0.8 (−1.6, 0) * 0.050
CWIT Inhibition scaled score (/19) 10.23 ± 2.6 10.76 ± 1.8 9.57 ± 3.3 1.19 (−3.23,0.84) 0.235 0.47 (−0.3,1.2) 1.21 (−0.9, 3.4) 0.250
CWIT Inhibition/switching scaled score (/19) 10.48 ± 2.1 10.65 ± 1.7 10.29 ± 2.6 0.36 (−1.96,1.24) 0.648 0.17 (−0.6, 0.9) 0.4 (−1.5, 2.3) 0.664
CWIT Contrast switching scaled score* 10.26 ± 1.9 9.88 ± 1.9 10.71 ± 1.9 −0.83 (−0.58,2.25) 0.239 −0.43 (−1.2, 0.3) −0.81 (−2.8, 1.2) 0.399
CWIT Inhibition total errors scaled score (/12–13) 10.68 ± 2.3 11.12 ± 1.5 10.14 ± 3.0 0.97 (−2.81,0.86) 0.279 0.43 (−0.3,1.2) 0.14 (−1.5, 1.8) 0.862
CWIT Inhibition/switching total errors scaled score (/12–13) 10.58 ± 2.2 10.94 ± 2.3 10.14 ± 2.0 0.8 (−2.39,0.79) 0.313 0.37 (−0.4,1.1) 0.68 (−1.4, 2.8) 0.499
TOL Total achievement scaled score (/19) 9.68 ± 1.9 9.71 ± 2.1 9.64 ± 1.8 0.06 (−1.51,1.38) 0.929 0.03 (−0.7, 0.8) −0.24 (−2.7, 2.3) 0.841
TOL Mean first move time scaled (/17–19) 9.35 ± 2.5 9.53 ± 3.0 9.14 ± 2.0 0.39 (−2.29,1.51) 0.680 0.15 (−0.6, 0.9) −1.11 (−4, 1.8) 0.427
TOL Time per move ratio scaled (/17–18) 9.06 ± 3.3 8.47 ± 3.5 9.79 ± 2.9 −1.32 (−1.11,3.74) 0.276 −0.40 (−1.1, 0.3) −2.76 (−6.5, 1) 0.135
TOL Move accuracy ratio scaled (/18) 8 ± 2.7 7.82 ± 2.9 8.21 ± 2.6 −0.39 (−1.64,2.42) 0.696 −0.14 (−0.9, 0.6) 0.92 (−2, 3.9) 0.227
TOL Total rule violations cumulative percentile rank (/100) 57.97 ± 32.9 60.29 ± 33.64 55.14 ± 33.1 5.15 (−29.8,19.49) 0.672 0.15 (−0.6, 0.9) 16.61 (−23,56.3) 0.632

Elevated = interleukin-10 ≥ 10 pg/ml; Normal = interleukin-10, 3–10 pg/ml; Values are presented as Mean ± SD for continuous variables, and n (%) for categorical variables. Adjusted mean differences presented in Mean ± SD and obtained by linear regression model adjusting for number of chronic diseases, education, and income. Alpha was originally set at p <.05 and Bonferroni corrected for multiple comparisons to 0.0025.- TMT: Trails Making Test CWIT: Color Word Interference Task; TOL: Tower of London. ^ Moderate-Large effect sizes per Cohen conventions. All scaled and contrast measures have normative mean values of 10. “Scaled” scores are scaled according to age norms.

*

CWIT contrast measures are better the closer they are to 10.